InvestorsHub Logo
Followers 37
Posts 6980
Boards Moderated 1
Alias Born 09/06/2014

Re: srinsocal post# 329295

Wednesday, 05/15/2024 5:11:30 PM

Wednesday, May 15, 2024 5:11:30 PM

Post# of 329911
That has nothing to do with what I said, but if you want to go THERE, BIEL WAS news-driven, once, and looking at the 10-year chart does give the potential investor an understanding of BIEL.

Ten years ago -- 2014 -- PRs got people excited because ten years ago investors had these things to get excited about:

* FDA clearance was on the horizon.
* The O/S was only 5.3 billion.
* Nobody knew the Whelans and Staelin would convert and dump billions of shares.
* The company had patents.
* The company maintained a Pink Current status.

That's ALL gone now. Today, a PR about another FDA clearance or another OEM Partner or another generation of devices or re-certifying the CE Mark won't excite anyone. They've released PR's in the past year about veterinary breakthroughs and more studies and a potential lawsuit against Mundipharma, but investors are weary of the hype. News doesn't excite anyone anymore unless it's news about REVENUES.

And where will significant revenues come from? They're operating on a shoestring, cutting expenses everywhere, trying to generate sales without a Sales VP, spending as little as possible on sales and marketing. When they get a $100,000 order it takes them two months to package and ship it.

Ilfeld's opioid study results might bump the PPS a tic or two. Woo hoo. We might see .0003. Be still my beating heart.